CTRI/2017/09/009720RecruitingPhase 4
Single arm open label trial to assess effectiveness of intravenous Ferric Carboxy Maltose (FCM) in improving haemoglobin level among pregnant women with moderate to severe anaemia attending a Sub District Hospital, district Faridabad, Haryana
Trial Snapshot
- Phase
- Phase 4
- Status
- Recruiting
- Enrollment
- 75
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Pregnant women in 16-32 weeks with anemia (Hb levels 5.0- 9.9 g/dl)
- •2.Those who give written consent and agree to cooperate for all measurements at different time points
Exclusion Criteria
- •1.Those having renal or hepatic impairment
- •2.Women having Hb <5gm%
- •3.Women having previous history of parenteral iron administration
- •4.Allergy to iron preparations
- •5.Known case of thalassemia, sickle cell anaemia or haemolytic anaemia.
Investigators
Similar Trials
Completed
Not Applicable
Single arm open-label study to evaluate efficacy and safety of low intensity extracorporeal shockwave therapy in prostate cancer patients with ED after radical prostatectomyErectile dysfunctionJPRN-UMIN000022514Hiroshima University50
Completed
Phase 4
A Clinical Trial to assess the effect, safety and tolerability of MIRCERA administered intravenously two weekly for treating the chronic renal anaemia in dialysis patients who are not receiving ESA treatment currentlyCTRI/2009/091/000452Roche Products India Pvt Ltd India220
Active, not recruiting
Not Applicable
A single arm open label study to assess the efficacy, safety and tolerability and of once-monthly administration of subcutaneous C.E.R.A. for the maintenance of haemoglobin levels in pre-dialysis patients with chronic renal anaemia. - UmbrellaChronic renal anemiaMedDRA version: 8.1Level: PTClassification code 10058116Term: Nephrogenic anaemiaEUCTR2006-006523-40-SERoche AB
Active, not recruiting
Not Applicable
A single arm open label study to assess the efficacy, safety and tolerability and of once-monthly administration of intravenous C.E.R.A. for the maintanance of haemoglobin levels in dialysis patients with chronic renal anaemia. - STABIChronic renal anaemiaMedDRA version: 9.1Level: LLTClassification code 10058123Term: Renal anaemiaEUCTR2007-002380-27-CZRoche s.r.o.200
Completed
Phase 2
To evaluate the IQ enhancing effect of Swarnprashana in Preschool ChildreCTRI/2023/04/052105Shri Krishna Govt Ayurvedic College and Hospital Kurukshetra Haryana60